Search

Your search keyword '"Cnossen M."' showing total 186 results

Search Constraints

Start Over You searched for: Author "Cnossen M." Remove constraint Author: "Cnossen M." Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
186 results on '"Cnossen M."'

Search Results

1. P-023: 2,3-DIPHOSPHOGLYCERATE DETECTION VIA DIRECT INFUSION HIGH RESOLUTION MASS SPECTROMETRY CORRELATES WITH QUANTITATIVE DETECTION IN BLOOD OF PATIENTS WITH SICKLE CELL DISEASE

3. PI-02: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE

4. Tachyphylaxis and reproducibility of desmopressin response in perioperative persons with nonsevere hemophilia A: implications for clinical practice

5. Tachyphylaxis and reproducibility of desmopressin response in perioperative persons with nonsevere hemophilia A:implications for clinical practice

8. PB0824 Prospective Longitudinal Evaluation Shows Increase of VWF and FVIII Activity with Age in Patients with Type 1 and 2 von Willebrand Disease

10. PB0205 High Prevalence of Heavy Menstrual Bleeding in Women with Rare Bleeding Disorders in the Netherlands: Retrospective Data from the RBiN Study

11. PB0203 Altered Bleeding Phenotype in Patients with Co-inheritance of Genetic Variants in Thrombosis and Hemostases Genes in Rare Bleeding Disorders

14. PB0623 An Enriched Population Pharmacokinetic Model for Recombinant Factor IX-Fc Fusion Including Young Children with Haemophilia B

15. Ethical aspects of hemophilia gene therapy:a qualitative interview study with stakeholders

16. Association between sports participation, factor VIII levels and bleeding in hemophilia A

17. Association between sports participation, factor VIII levels and bleeding in hemophilia A

18. Primary versus early secondary referral to a specialized neurotrauma center in patients with moderate/severe traumatic brain injury: a CENTER TBI study

19. Primary versus early secondary referral to a specialized neurotrauma center in patients with moderate/severe traumatic brain injury: a CENTER TBI study

20. Variation in Structure and Process of Care in Traumatic Brain Injury: Provider Profiles of European Neurotrauma Centers Participating in the CENTER-TBI Study

22. S266: OXYGEN GRADIENT EKTACYTOMETRY-DERIVED BIOMARKERS ARE ASSOCIATED WITH THE OCCURRENCE OF ACUTE COMPLICATIONS IN SICKLE CELL DISEASE

23. P1500: 2,3-DIPHOSPHOGLYCERATE DETECTION VIA DIRECT INFUSION HIGH RESOLUTION MASS SPECTROMETRY CORRELATES WITH QUANTITATIVE DETECTION IN BLOOD OF PATIENTS WITH SICKLE CELL DISEASE

24. P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE

25. In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients

26. Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: To WiN study

27. In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients

28. Emicizumab Dosing in Children and Adults with Hemophilia A: Simulating a User-Friendly and Cost-Efficient Regimen

30. Variation in the practice of tracheal intubation in Europe after traumatic brain injury: a prospective cohort study

31. Health-related quality of life after traumatic brain injury: deriving value sets for the QOLIBRI-OS for Italy, The Netherlands and The United Kingdom

32. Machine learning algorithms performed no better than regression models for prognostication in traumatic brain injury

33. Health-related quality of life after traumatic brain injury : deriving value sets for the QOLIBRI-OS for Italy, The Netherlands and The United Kingdom

34. Variation in neurosurgical management of traumatic brain injury: a survey in 68 centers participating in the CENTER-TBI study

35. BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease

36. Inhibitor development and mortality in non-severe hemophilia A

42. CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease

44. Correction to: Variation in neurosurgical management of traumatic brain injury: a survey in 68 centers participating in the CENTER-TBI study (Acta Neurochirurgica, (2019), 161, 3, (435-449), 10.1007/s00701-018-3761-z)

45. Product type and the risk of inhibitor development in nonsevere haemophilia A patients

Catalog

Books, media, physical & digital resources